Personalized Translational Platform for Biomarker Discovery in Brain

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05023551` - Study of DSP-0390 in Patients With Recurrent High-Grade Glioma	Early Phase 1
Terminated	`NCT01902771` - Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors	Phase 1
Active, not recruiting	`NCT02655601` - Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001	Phase 2
Terminated	`NCT03690869` - REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma	Phase 1/Phase 2
Completed	`NCT01466686` - Low Dose Radiation Therapy for Glioblastoma Multiforme	Phase 2
Recruiting	`NCT05212272` - MRI in High-Grade Glioma Patients Undergoing Chemoradiation
Recruiting	`NCT05925218` - Circulating Tumor DNA Collection From Patients With High Grade Gliomas
Active, not recruiting	`NCT04911621` - Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma	Phase 1/Phase 2
Not yet recruiting	`NCT06333899` - Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion	Early Phase 1
Recruiting	`NCT04734444` - SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue	N/A
Completed	`NCT03775369` - Glioma and Exercising	N/A
Completed	`NCT02022644` - Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma	Phase 1
Completed	`NCT00780819` - Borderzone Sampling	N/A
Recruiting	`NCT06072586` - Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) Participants With EGFR Alterations or Fusions	Early Phase 1
Completed	`NCT01390948` - A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma	Phase 2
Recruiting	`NCT03952598` - Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy	N/A
Recruiting	`NCT05630664` - Liquid Biopsy in High-grade Gliomas and Meningiomas
Recruiting	`NCT05298995` - GD2-CAR T Cells for Pediatric Brain Tumours	Phase 1
Completed	`NCT01222754` - Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas	Phase 1
Recruiting	`NCT05278208` - Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors	Phase 1/Phase 2

NCT number	NCT01240161
Study type	Observational
Source	Brigham and Women's Hospital
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	March 2016

Personalized Translational Platform for Biomarker Discovery in Brain Tumors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms